Intraday mover · MRNA · Healthcare

Moderna Inc (MRNA) lands on active screen after a 177.0% move

The biotech stock drew heavy market attention while the today intraday price path pointed to cooling from the session’s early level.

Moderna Inc
Latest63.32 USD
1W move7.0%
Volume1.0x
TrendActive
Trading terminal view of Moderna stock data with biotechnology laboratory equipment.

Market update

What happened

Moderna Inc (MRNA) was highlighted by the active-mover screen, with market data showing unusually heavy turnover in the stock. The today intraday price path showed the shares at 143.08 USD, down 4.1% from an intraday start near 149.18 USD.

The latest weekly market close was 63.32 USD, leaving Moderna up 7.0% over one week and 35.1% over twelve weeks. The trend signal remained active, but Market Dynamics showed pressure and Relative Strength was modest at 31.2, making the setup mixed.

Continue your research

Explore MRNA across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

MRNA coverage

Evidence context